| 摘要 |
Substituted 5,12-diaza-benzoanthracene analogues are provided, of the Formul a (I) wherein variables are as described herein. Such compounds are ligands th at may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals a nd livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using suc h ligands for receptor localization studies.
|
